补体因子B(CFB)遗传编码变异与肛周克罗恩病风险增加相关,并导致CFB裂解和吞噬功能受损
本研究通过免疫芯片荟萃分析三个独立队列的4056例肛周克罗恩病(pCD)和11088例克罗恩病(CD)患者,发现CFB基因rs4151651(G252S)与pCD相关;功能实验显示S252型CFB与C3b结合减少、裂解受损,补体驱动的吞噬和细胞因子分泌降低,纯合风险患者血清使巨噬细胞吞噬显著下降。
要点
- pCD与结肠受累、OmpC和ASCA血清学及血清学四分位总分相关。
- rs4151651(CFB G252S)在三个队列中均与pCD相关。
- S252 CFB与C3b结合减少、裂解受损,吞噬和细胞因子分泌降低。
核心结论
- pCD相关rs4151651是CFB的功能丧失突变,损害其裂解、替代补体途径激活和病原体吞噬,提示替代补体途径和CFB参与pCD病因。
研究设计与样本
- 基于免疫芯片对三个独立队列的4056例pCD和11088例CD患者进行荟萃分析。
- 将rs4151651风险等位基因通过定点诱变引入人CFB质粒。
- 在无细胞实验中检测重组G252或S252 CFB与C3b的结合及其裂解。
- 通过流式细胞术评估重组CFB或来自CFB风险、保护性CD或健康受试者血清存在下的巨噬细胞吞噬作用。
主要发现
- 肛周并发症与结肠受累、OmpC和ASCA血清学及血清学四分位总分相关。
- 在三个队列中均发现pCD与CFB非 synonymous SNP rs4151651(G252S)的遗传关联。
- 与G252 CFB相比,重组S252 CFB与C3b结合减少、裂解受损,补体驱动的吞噬作用和细胞因子分泌减少。
- 丝氨酸252在CFB中产生一个新的糖基化位点。
- 与无风险血清相比,纯合风险患者血清显示巨噬细胞吞噬作用显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Perianal Crohn's disease (pCD) occurs in up to 40% of patients with CD and is associated with poor quality of life, limited treatment responses and poorly understood aetiology. We performed a genetic association study comparing CD subjects with and without perianal disease and subsequently performed functional follow-up studies for a pCD associated SNP in Complement Factor B (CFB). DESIGN: Immunochip-based meta-analysis on 4056 pCD and 11 088 patients with CD from three independent cohorts was performed. Serological and clinical variables were analysed by regression analyses. Risk allele of rs4151651 was introduced into human CFB plasmid by site-directed mutagenesis. Binding of recombinant G252 or S252 CFB to C3b and its cleavage was determined in cell-free assays. Macrophage phagocytosis in presence of recombinant CFB or serum from CFB risk, or protective CD or healthy subjects was assessed by flow cytometry. RESULTS: Perianal complications were associated with colonic involvement, OmpC and ASCA serology, and serology quartile sum score. We identified a genetic association for pCD (rs4151651), a non-synonymous SNP (G252S) in CFB, in all three cohorts. Recombinant S252 CFB had reduced binding to C3b, its cleavage was impaired, and complement-driven phagocytosis and cytokine secretion were reduced compared with G252 CFB. Serine 252 generates a de novo glycosylation site in CFB. Serum from homozygous risk patients displayed significantly decreased macrophage phagocytosis compared with non-risk serum. CONCLUSION: pCD-associated rs4151651 in CFB is a loss-of-function mutation that impairs its cleavage, activation of alternative complement pathway, and pathogen phagocytosis thus implicating the alternative complement pathway and CFB in pCD aetiology.
引用
- Akhlaghpour M, Haritunians T, More SK, et al. Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut. 2023. PMID: 37080587. doi:10.1136/gutjnl-2023-329689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。